title: Association of serum B-cell activating factor level and proportion of memory and transitional B cells with clinical response after rituximab treatment of bullous pemphigoid patients.
authors.affiliation: Department of Dermatology, Duke University School of Medicine, Durham, North Carolina, USA; Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA. Electronic address: Russell.Hall@duke.edu.
authors.forename: Russell P
authors.initials: RP
authors.lastname: Hall
authors.affiliation: Department of Dermatology, Duke University School of Medicine, Durham, North Carolina, USA; Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.
authors.forename: Robert D
authors.initials: RD
authors.lastname: Streilein
authors.affiliation: Department of Dermatology, Duke University School of Medicine, Durham, North Carolina, USA; Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.
authors.forename: Deborah L
authors.initials: DL
authors.lastname: Hannah
authors.affiliation: Department of Dermatology, Duke University School of Medicine, Durham, North Carolina, USA; Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.
authors.forename: Patrice D
authors.initials: PD
authors.lastname: McNair
authors.affiliation: Department of Dermatology, University of Iowa School of Medicine, Iowa City, Iowa, USA.
authors.forename: Janet A
authors.initials: JA
authors.lastname: Fairley
authors.affiliation: Department of Dermatology, Duke University School of Medicine, Durham, North Carolina, USA; Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.
authors.forename: Arash
authors.initials: A
authors.lastname: Ronaghy
authors.affiliation: Department of Dermatology, Duke University School of Medicine, Durham, North Carolina, USA; Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.
authors.forename: Kim D
authors.initials: KD
authors.lastname: Edhegard
authors.affiliation: Department of Dermatology, Duke University School of Medicine, Durham, North Carolina, USA; Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.
authors.forename: Marc C
authors.initials: MC
authors.lastname: Levesque
mesh_terms: D000368:Aged; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D001323:Autoantibodies / Q000097:blood; D053264:B-Cell Activating Factor / Q000097:blood*; D001768:Blister / Q000188:drug therapy; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood; D007155:Immunologic Factors / Q000627:therapeutic use; D007156:Immunologic Memory / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D010391:Pemphigoid, Bullous / Q000188:drug therapy*; D054448:Precursor Cells, B-Lymphoid / Q000166:cytology* / Q000187:drug effects; D011241:Prednisone / Q000627:therapeutic use; D000069283:Rituximab; D016896:Treatment Outcome
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D001323:Autoantibodies; D053264:B-Cell Activating Factor; D007074:Immunoglobulin G; D007155:Immunologic Factors; C505719:TNFSF13B protein, human; D000069283:Rituximab; D011241:Prednisone